人工智能是空想吗?为何法律问题对人工智能自主性构成重大障碍
文章讨论人工智能(AI)在放射科的应用前景,指出尽管技术障碍与成本终将克服,但法律障碍威胁AI对放射学科的影响。AI错误的法律责任、产品责任法对AI的潜在适用以及美国FDA可能将自主AI归类为医疗器械的不确定性,将影响AI是作为简单决策支持工具还是发展为医疗团队的自主成员。文章呼吁立法明确AI的责任风险以不阻碍技术发展。
要点
- AI错误的法定责任归属将决定AI在放射科是决策支持工具还是自主成员。
- 产品责任法对AI的潜在适用及美国FDA可能将自主AI归类为医疗器械带来不确定性。
- 法律对待AI的当前模糊性使厂商、放射科医生和医院无法可靠评估实施AI的责任。
核心结论
- AI在放射科的自主应用面临重大法律障碍,需立法明确责任风险以不阻碍技术发展。
研究设计与样本
- 本文为观点文章,讨论AI在放射科的法律障碍,未涉及研究设计、样本量或设备序列。
临床应用与阅片要点
- 作者认为,AI在放射科及医疗保健的倡导者需要游说立法行动,以更好地明确AI的责任风险,且方式不阻碍技术发展。
- 原文未据此给出日常阅片或报告的具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Proponents of artificial intelligence (AI) technology have suggested that in the near future, AI software may replace human radiologists. Although assimilation of AI into the specialty has occurred more slowly than predicted, developments in machine learning, deep learning, and neural networks suggest that technologic hurdles and costs will eventually be overcome. However, beyond these technologic hurdles, formidable legal hurdles threaten the impact of AI on the specialty. Legal liability for errors committed by AI will influence the ultimate role of AI within radiology and also influence whether AI remains a simple decision support tool or develops into an autonomous member of the health care team. Additional areas of uncertainty include the potential application of products liability law to AI and the approach taken by the U.S. FDA in potentially classifying autonomous AI as a medical device. The current ambiguity of the legal treatment of AI will profoundly influence development of autonomous AI given that vendors, radiologists, and hospitals will be unable to reliably assess their liability associated with implementing such tools. Advocates of AI in radiology and health care in general need to lobby for legislative action to better clarify the liability risks of AI in a way that does not deter technologic development.
引用
- Mezrich. Is Artificial Intelligence (AI) a Pipe Dream? Why Legal Issues Present Significant Hurdles to AI Autonomy. AJR Am J Roentgenol. 2022. PMID: 35138133. doi:10.2214/AJR.21.27224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。